Want to see OM full AI Analyst Report?

Outset Medical (OM) Price & Analysis

395 Followers

OM Stock Chart & Stats

$4.35

-$0.10(-9.09%)

At close: Jan 08 4:00 PM EST

$4.35

-$0.10(-9.09%)

Day’s Range― - ―

52-Week Range$3.00 - $19.60

Previous CloseN/A

Volume1.92M

Average Volume (3M)266.12K

Market Cap

$80.73M

Enterprise Value$15.46

Total Cash (Recent Filing)$156.71M

Total Debt (Recent Filing)$101.61M

Price to Earnings (P/E)―

Beta1.88

Next Earnings

Aug 05, 2026

EPS Estimate

-0.72

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)-4.16

Shares Outstanding18,537,241

10 Day Avg. Volume142,515

30 Day Avg. Volume266,120

Financial Highlights & Ratios

PEG Ratio<0.01

Price to Book (P/B)0.44

Price to Sales (P/S)0.47

P/FCF Ratio-1.20

Enterprise Value/Market Cap<0.01

Enterprise Value/Revenue<0.01

Enterprise Value/Gross Profit<0.01

Enterprise Value/Ebitda>-0.01

Forecast

1Y Price Target

$7.67

Price Target Upside76.25% Upside

Rating ConsensusModerate Buy

Number of Analyst Covering3

EPS Forecast (FY)-2.89

Revenue Forecast (FY)$126.60M

Bulls Say, Bears Say

Bulls Say

Recurring Revenue StabilityA durable revenue base from consumables and services (~70% of sales) reduces sensitivity to capital order timing. Stable per-treatment consumable pull-through and service contracts support predictable cash flow and unit economics as installed base grows over months.

Gross Margin ExpansionMaterial margin improvement reflects stronger unit economics and cost control; higher product margins and service margin recovery create a structural pathway to sustained profitability if scale continues. This supports long-term durability of operating leverage.

HCA Multi‑Year AgreementA committed multi-year purchase from a major hospital network provides multi-year revenue visibility and predictable consumables demand. It strengthens hospital footprint, supports recurring revenue growth, and validates product adoption in large health systems.

Bears Say

Deep Unprofitability & Negative Cash FlowDespite margin gains, very large trailing losses and persistent negative free cash flow represent a structural funding risk. Continued operating losses can erode flexibility and require sustained revenue growth or external financing to avoid dilutive or restrictive measures.

Revenue Softness And LumpinessVolatility in capital sales and quarter-to-quarter lumpiness hampers reliable revenue progression and hinders efficient capacity utilization. This undermines predictability of reaching breakeven and complicates multi-quarter planning for production, sales, and service investments.

Dependence On Next‑Gen TableauKey growth and margin improvement assumptions depend on successful product launch and adoption. Any delays, slower clinical acceptance, or weaker-than-expected uptake would materially impair projected back-half revenue and the path to sustained profitability.

Outset Medical News

Outset Medical Secures Multi‑Year HCA Hemodialysis Agreement

The latest announcement is out from Outset Medical ( ($OM) ). On June 14, 2026, Outset Medical, Inc....

1M ago

Outset Medical Shareholders Back Board and Governance Measures

Outset Medical ( ($OM) ) has issued an announcement. On June 4, 2026, Outset Medical held its annual...

1M ago

Outset Medical Announces Executive Vice President Marc Nash Departure

Outset Medical ( ($OM) ) has provided an update. On May 26, 2026, Outset Medical, Inc. announced that...

2M ago

Outset Medical Bets on Margin Gains and Next-Gen Tableau

Outset Medical, Inc. (($OM)) has held its Q1 earnings call. Read on for the main highlights of the...

2M ago

Outset Medical price target lowered to $10 from $12 at TD Cowen

TD Cowen analyst Joshua Jennings lowered the firm’s price target on Outset Medical (OM) to $10 from $12...

2M ago

Outset Medical price target lowered to $6 from $8 at Stifel

Stifel lowered the firm’s price target on Outset Medical (OM) to $6 from $8 and keeps a Buy...

2M ago

Outset Medical reports Q1 EPS ($1.03), consensus (79c)

Reports Q1 revenue $27.86M, consensus $28.9M. “We delivered a solid first quarter and continued to make meaningful progress...

2M ago

Outset Medical backs FY26 revenue view $125M-$130M, consensus $126.77M

The company said, “Outset reiterated its 2026 revenue guidance of $125 million to $130 million, a 5% to...

2M ago

AI Models Turn Cautiously More Positive on Outset Medical as Turnaround Takes Shape

Outset Medical (OM) received net upgrades from three AI models tracked by TipRanks, as improving operating trends and...

3M ago

Outset Medical: Tablo Platform’s System‑Wide Insights Drive Strategic Health System Adoption and Support Buy Rating

Analyst Josh Jennings from TD Cowen maintained a Buy rating on Outset Medical and keeping the price target...

4M ago

Outset Medical Earnings Call Highlights Margin Turnaround

Outset Medical, Inc. (($OM)) has held its Q4 earnings call. Read on for the main highlights of the...

5M ago

Outset Medical price target lowered to $12 from $15 at TD Cowen

TD Cowen lowered the firm’s price target on Outset Medical (OM) to $12 from $15 and keeps a...

5M ago

Outset Medical price target lowered to $15 from $17 at BTIG

BTIG analyst Marie Thibault lowered the firm’s price target on Outset Medical (OM) to $15 from $17 and...

5M ago

Outset Medical: Improving Visibility, Stronger Margins, and Next-Gen Tablo Support Buy Rating and $15 Target

BTIG analyst Marie Thibault reiterated a Buy rating on Outset Medical yesterday and set a price target of...

5M ago

OM FAQ

What was Outset Medical, Inc.’s price range in the past 12 months?

Outset Medical, Inc. lowest stock price was $3.00 and its highest was $19.60 in the past 12 months.

What is Outset Medical, Inc.’s market cap?

Outset Medical, Inc.’s market cap is $80.73M.

When is Outset Medical, Inc.’s upcoming earnings report date?

Outset Medical, Inc.’s upcoming earnings report date is Aug 05, 2026 which is in 17 days.

How were Outset Medical, Inc.’s earnings last quarter?

Outset Medical, Inc. released its earnings results on May 07, 2026. The company reported -$0.83 earnings per share for the quarter, missing the consensus estimate of -$0.79 by -$0.04.

Is Outset Medical, Inc. overvalued?

According to Wall Street analysts Outset Medical, Inc.’s price is currently Undervalued. Get more investment ideas with TipRanks Premium

Does Outset Medical, Inc. pay dividends?

Outset Medical, Inc. does not currently pay dividends.

What is Outset Medical, Inc.’s EPS estimate?

Outset Medical, Inc.’s EPS estimate is -0.72.

How many shares outstanding does Outset Medical, Inc. have?

Outset Medical, Inc. has 18,537,241 shares outstanding.

What happened to Outset Medical, Inc.’s price movement after its last earnings report?

Outset Medical, Inc. reported an EPS of -$0.83 in its last earnings report, missing expectations of -$0.79. Following the earnings report the stock price went down -21.047%.

Which hedge fund is a major shareholder of Outset Medical, Inc.?

Currently, no hedge funds are holding shares in OM

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Outset Medical Stock Smart Score

Underperform

Fundamentals

Return on Equity

-55.88%

Trailing 12-Months

Asset Growth

-17.18%

Trailing 12-Months

Top Smart Score Stocks >

Company Description

Outset Medical, Inc.

Outset Medical, Inc. is a medical technology firm that specializes in developing hemodialysis systems. The company's primary product is the Tablo Hemodialysis System, a compact console designed to deliver dialysis treatment in various environments, including hospitals and patients' homes. This innovative system boasts integrated water purification, on-demand production of dialysate, and advanced software complete with connectivity features. Founded in 2003, the company initially operated under the name Home Dialysis Plus, Ltd. before rebranding to Outset Medical, Inc. in January 2015. Its corporate headquarters are located in San Jose, California.

Outset Medical (OM) Earnings & Revenues

Historic Earnings Reports

OM Revenue Breakdown

47.04% Consoles

32.37% Consumables

20.59% Service and other revenue

OM Stock 12 Month Forecast

Average Price Target

$7.67

▲(76.25% Upside)

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"2":"$2","21":"$21","6.75":"$6.75","11.5":"$11.5","16.25":"$16.25"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":10,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$10.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":7.666666666666667,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$7.67</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":6,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$6.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[2,6.75,11.5,16.25,21],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Oct<br/>2025","6":"Jan<br/>2026","9":"Apr<br/>2026","12":"Jul<br/>2026","25":"Jul<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,5.1,5.476923076923077,5.8538461538461535,6.230769230769231,6.607692307692307,6.984615384615385,7.361538461538462,7.7384615384615385,8.115384615384615,8.492307692307692,8.86923076923077,9.246153846153845,9.623076923076923,{"y":10,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,5.1,5.297435897435897,5.494871794871795,5.692307692307692,5.889743589743589,6.087179487179487,6.2846153846153845,6.482051282051282,6.67948717948718,6.876923076923077,7.074358974358974,7.271794871794873,7.469230769230769,{"y":7.666666666666667,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,5.1,5.169230769230769,5.2384615384615385,5.3076923076923075,5.3769230769230765,5.446153846153846,5.515384615384615,5.584615384615384,5.653846153846153,5.723076923076923,5.792307692307692,5.861538461538462,5.930769230769231,{"y":6,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":20.73,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":15.04,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":13.74,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":14.02,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":13.12,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4.22,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3.71,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4.97,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3.57,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3.84,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4.36,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4.91,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":5.1,"date":1782864000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Detailed Analyst Forecast >